Randomized trial · people
Kisspeptin-10: daily 8 h infusions kept LH raised for 12 days in men
Checked against the paper Randomized trialPublished by PepVault
The takeaway
In healthy men, an on-off daily schedule of kisspeptin-10 kept LH and FSH rises going for 12 days, while nonstop infusion lost the LH and FSH effect by day 5.
- Kind
- Randomized trial
- Studied in
- People
- Number studied
- 15
- Published
- 2026
- Journal
- Eur J Endocrinol
What they tested
The team tested whether kisspeptin-10 given under the skin over days could keep reproductive hormones raised in healthy men, and which schedule worked best.
How the study was done
A randomized, single-blinded, placebo-controlled study in 15 healthy men split across three parts (7, 4 and 7 men), with 12 men acting as controls. Men first got single 8 h under-the-skin infusions at 1.25-10.0 nmol/kg/h, then either a nonstop 5-day infusion (180 nmol/h) or 12 days of one 8 h infusion each day (150 nmol/h).

What they found
Single 8 h infusions raised LH (luteinizing hormone), FSH (follicle-stimulating hormone) and testosterone more as the dose went up, compared with vehicle, the inactive carrier solution. With the nonstop 5-day infusion, testosterone stayed raised, but LH and FSH ended up similar to vehicle. With daily 8 h infusions, the mean LH rise was +1.68 ± 0.25 on day 1 and +1.14 ± 0.33 on day 12, versus -0.16 ± 0.19 with vehicle, a significant difference. After the 12 days, a 1 nmol/kg bolus (a single quick dose) of kisspeptin-10 still raised LH and FSH, which the team read as a sign the kisspeptin receptor still worked.
What it doesn’t show
Each part of the study had only 4 to 7 men, all healthy, and the longest schedule lasted 12 days. It did not test people with reproductive disorders, women, or longer use.
The paper
Yeung et al. Chronic subcutaneous kisspeptin-10 stimulates gonadotropin secretion for 12 days in healthy men. Eur J Endocrinol. 2026.
The compound
More studies on Kisspeptin-10
- Kisspeptin-10 raised osteocalcin by up to 20.3% in healthy menRandomized trial · people · 2022
- Every study on Kisspeptin-10
Researched and drafted with AI, then checked claim by claim against the primary sources linked below by a separate review pass. Published by PepVault. Last reviewed . Spot an error? feedback@pepvault.app. How we research. This page reports one study; it is not medical advice.